Evolution of the Effect of Canine Parvovirus (CPV) AB Value on Recovery Time and Survival Rate in Dogs Infected with CPV

Abstract

Parvoviral enteritis is a viral disease that commonly presents with clinical symptoms such as vomiting, hemorrhagic enteritis, and lethargy. Many studies have been conducted on the prevention and treatment of the disease. Prevention methods are more prominent than treatment methods, and vaccination is of utmost importance. If vaccination is not performed at a sufficient level or with appropriate procedures, the desired level of immunity is not achieved, and full protection cannot be provided. In our study, stool samples taken from patients with sterile swabs were immersed in dilution solution and waited, then dropped into the test kit with the help of a vacuum pipette, and individuals with double lines were considered parvoviral enteritis was accepted as positive. Blood was taken from patients with positive test results into a gel yellow capped blood collection tube and sera were obtained by centrifugation. 100 microliters of the mixture were taken and dropped into the relevant section of the CPV Ab test kit and evaluated with the V - check V200 automatic veterinary hormone analysis and immunity test device after 10 minutes. Serum parvovirus Ab levels of 40 patients (22 female, 18 male) who were vaccinated in various numbers were examined with the V-check V 200 automatic veterinary hormone analysis and immunity test device. Data were obtained showing that 80% of patients with high and medium level protection survived and 52.5% of all patients survived. It was observed that factors such as gender and number of vaccinations had no effect on survival. The possibility of 2 doses of vaccination with a large sample size was considered.